Showing results (91-100 of 215) with videos related to
Sort By:
Pageof 22
Hepatitis Monthly|August 8, 2013
The Effect of Peginterferon Alpha-2a vs. Peginterferon Alpha-2b in Treatment of Naive Chronic HCV Genotype-4 Patients: A Single Centre Egyptian StudyMaissa El Raziky, Waleed Fouad Fathalah, Wafaa Ahmed El-Akel, et al.Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|November 12, 2013
Fibroscan of chronic HCV patients coinfected with schistosomiasisGamal Esmat, Aisha Elsharkawy, Wafaa El Akel, et al.European Journal of Gastroenterology & Hepatology|March 22, 2019
Clinical impact of serum α-fetoprotein and its relation on changes in liver fibrosis in hepatitis C virus patients receiving direct-acting antiviralsRabab Fouad, Aisha Elsharkawy, Shereen Abdel Alem, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|November 18, 2022
Serial changes in renal indices in chronic HCV patients with and without HIV co-infection receiving sofosbuvir and tenofovir-based therapiesShereen Abdel Alem, Naeema El Garhy, Engy El Khateeb, et al.Archives of Virology|March 25, 2018
Correction to: Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of OccludinDalia S Elhelw, Sarah E Riad, Heba Shawer, et al.Infection|August 21, 2020
Renal profile of chronic hepatitis C patients with sofosbuvir-based therapyMohammad El-Sayed, Zeinab Abdellatif, Aisha Elsharkawy, et al.Archives of Virology|June 24, 2017
Ectopic delivery of miR-200c diminishes hepatitis C virus infectivity through transcriptional and translational repression of OccludinDalia S Elhelw, Sarah E Riad, Heba Shawer, et al.Journal of Gastroenterology and Hepatology|February 9, 2017
Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferonAisha Elsharkawy, Shereen Abdel Alem, Rabab Fouad, et al.European Journal of Gastroenterology & Hepatology|August 11, 2018
High sustained virologic response rate using generic directly acting antivirals in the treatment of chronic hepatitis C virus Egyptian patients: single-center experienceSaeed M El-Nahaas, Rabab Fouad, Aisha Elsharkawy, et al.Journal of Clinical Microbiology|September 21, 2012
NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patientsAhmed El-Shamy, Ikuo Shoji, Wafaa El-Akel, et al.Pageof 22